Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > NanoInk Awarded Three Patents for Its DPN Technology for Nanoscale Manufacturing

Abstract:
NanoInk, Inc., an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science, pharmaceutical, and semiconductor industries, announced today it has been awarded three additional patents pertaining to its core patented Dip Pen Nanolithography® (DPN®) patterning technology for nanoscale manufacturing.

NanoInk Awarded Three Patents for Its DPN Technology for Nanoscale Manufacturing

SKOKIE, IL | Posted on November 1st, 2007

The U.S. Patent and Trademark Office granted patent number 7,098,056, entitled Apparatus, Materials, and Methods for Fabrication and Catalysis. The patented technology involves the use of DPN patterning for immobilizing catalyst materials and related compounds on surfaces. These regimes are shown to be primarily useful for growing uniform polymeric structures such as carbon nanotubes.

In addition, patent number 7,199,305, Protosubstrates describes the design, method of fabrication and compatibility with nanolithography of a prototyping tool. The tool consists primarily of a surface suitable for designing tests of nanoscale materials (most notably electronic) and components for connecting that surface to external, conventional test equipment.

Finally, patent number 7,279,046, Method and Apparatus for Aligning Patterns on a Substrate, describes a method of aligning features created via DPN patterning with extremely high precision. The method, which works for successive DPN patterning steps and integration with other forms of lithography, employs Scanning Probe Microscopy, integrated video capture, and novel software algorithms.

NanoInk's growing patent portfolio is composed of over 120 total documents in 38 families, including both owned and licensed properties. Robert Janosky, NanoInk president and COO, said, "NanoInk continues to invest in its future by developing and patenting powerful and innovative technologies which will enable the commercialization of numerous methods and products as the nanotechnology manufacturing space matures."

Other related intellectual property activity at NanoInk, Inc. includes two reexaminations. Recently, in an ex parte reexamination proceeding initiated by NanoInk, the US Patent & Trademark Office (PTO) cancelled all but three claims of BioForce Nanosciences, Inc.'s patent number 6,573,369. Moreover, the PTO narrowed the scope of the three remaining claims in this ex parte reexamination. Furthermore, the PTO has also granted NanoInk's reexamination request for a counterpart divisional BioForce patent, U.S. Patent No. 6,998,228, and this reexamination remains pending.

Tom Levesque, vice president of NanoInk's Dip Pen Nanolithography Business, stated, "While one may question the PTO's decision to allow three narrow claims, we are nevertheless pleased to see that the PTO substantially reduced the scope of the initial patent. NanoInk will continue to aggressively pursue every means to defend our intellectual property investments."

####

About NanoInk, Inc.
NanoInk, Inc. is an emerging growth technology company specializing in nanometer-scale manufacturing and applications development for the life science and semiconductor industries. With DPN®, a patented and proprietary nanofabrication technology that allows for unmatched flexibility and accuracy, and also its high-resolution Nanoencryption™ technology, NanoInk is able to offer its pharmaceutical customers innovative solutions to fight counterfeiting and illegal diversion of blockbuster pharmaceutical products. Other key applications include nanoscale additive repair and nanoscale rapid prototyping. Located in the new Illinois Science + Technology Park, north of Chicago, NanoInk currently has over 120 issued or pending patents and patent applications filed worldwide and has licensing agreements with Northwestern University, Stanford University, and the University of Illinois at Urbana-Champaign and the Georgia Institute of Technology.

For more information, please click here

Contacts:
oshua Taustein
Dresner Corporate Services for NanoInk
312-780-7219

David Gutierrez
Dresner Corporate Services for NanoInk
312-780-7204

Copyright © Market Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Chip Technology

New chip opens door to AI computing at light speed February 16th, 2024

HKUST researchers develop new integration technique for efficient coupling of III-V and silicon February 16th, 2024

Electrons screen against conductivity-killer in organic semiconductors: The discovery is the first step towards creating effective organic semiconductors, which use significantly less water and energy, and produce far less waste than their inorganic counterparts February 16th, 2024

NRL discovers two-dimensional waveguides February 16th, 2024

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

Printing/Lithography/Inkjet/Inks/Bio-printing/Dyes

Presenting: Ultrasound-based printing of 3D materials—potentially inside the body December 8th, 2023

Simple ballpoint pen can write custom LEDs August 11th, 2023

Disposable electronics on a simple sheet of paper October 7th, 2022

Newly developed technique to improve quantum dots color conversion performance: Researchers created perovskite quantum dot microarrays to achieve better results in full-color light-emitting devices and expand potential applications June 10th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project